← Back to all clusters

Cluster 548

5 diseases · 7 shared-gene connections
5 Diseases
10 Unique genes
0.266 Avg. similarity score
Headache Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Headache 4 4 10
Angiofollicular ganglionic hyperplasia 3 3 1
Angiolymphoid hyperplasia 3 3 1
Castleman disease 3 3 1
Congenital microtia 1 1 1

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
IL6 4 / 5 Angiofollicular ganglionic hyperplasia, Angiolymphoid hyperplasia, Castleman disease, Headache
PRKRA 2 / 5 Congenital microtia, Headache
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
JAK-STAT signaling pathway KEGG 3 / 168 21.4× 3.00e-4 4.51e-3 ✓ sig.
Interleukin-10 signaling Reactome 2 / 47 51.1× 6.61e-4 8.28e-3 ✓ sig.
Malaria KEGG 2 / 50 48.0× 7.48e-4 9.09e-3 ✓ sig.
Coronavirus disease - COVID-19 KEGG 3 / 238 15.1× 8.32e-4 9.85e-3 ✓ sig.
Vitamin E Reactome 1 / 1 1,201× 8.33e-4 9.85e-3 ✓ sig.
Cytokine-cytokine receptor interaction KEGG 3 / 298 12.1× 1.59e-3 1.61e-2 ✓ sig.
Cytosolic DNA-sensing pathway KEGG 2 / 83 28.9× 2.05e-3 1.93e-2 ✓ sig.
IL-17 signaling pathway KEGG 2 / 94 25.6× 2.62e-3 2.32e-2 ✓ sig.
PI3K-Akt signaling pathway KEGG 3 / 361 10.0× 2.76e-3 2.40e-2 ✓ sig.
Hematopoietic cell lineage KEGG 2 / 100 24.0× 2.96e-3 2.52e-2 ✓ sig.
Toll-like receptor signaling pathway KEGG 2 / 109 22.0× 3.50e-3 2.83e-2 ✓ sig.
Vasopressin-like receptors Reactome 1 / 6 200× 4.99e-3 3.64e-2 ✓ sig.
Measles KEGG 2 / 139 17.3× 5.63e-3 3.95e-2 ✓ sig.
Alcoholic liver disease KEGG 2 / 144 16.7× 6.03e-3 4.12e-2 ✓ sig.
CD163 mediating an anti-inflammatory response Reactome 1 / 9 133× 7.47e-3 4.73e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
response to prostaglandin E GO:0034695 2 / 11 340× 1.41e-5 7.12e-4 ✓ sig.
positive regulation of ossification GO:0045778 2 / 21 178× 5.38e-5 1.95e-3 ✓ sig.
cell surface receptor signaling pathway via STAT GO:0097696 2 / 28 133× 9.67e-5 3.01e-3 ✓ sig.
response to steroid hormone GO:0048545 2 / 30 125× 1.11e-4 3.34e-3 ✓ sig.
response to peptide hormone GO:0043434 2 / 50 74.7× 3.11e-4 6.97e-3 ✓ sig.
response to activity GO:0014823 2 / 52 71.9× 3.37e-4 7.28e-3 ✓ sig.
response to glucocorticoid GO:0051384 2 / 53 70.5× 3.50e-4 7.49e-3 ✓ sig.
humoral immune response GO:0006959 2 / 58 64.4× 4.19e-4 8.47e-3 ✓ sig.
regulation of astrocyte activation GO:0061888 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
glucagon secretion GO:0070091 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
positive regulation of hindgut contraction GO:0060450 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
negative regulation of establishment of blood-brain barrier GO:0090212 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
negative regulation of immature T cell proliferation GO:0033087 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
external genitalia morphogenesis GO:0035261 1 / 1 1,869× 5.35e-4 9.88e-3 ✓ sig.
female pregnancy GO:0007565 2 / 80 46.7× 7.97e-4 1.28e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Angiofollicular ganglionic hyperplasia Angiolymphoid hyperplasia 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Angiofollicular ganglionic hyperplasia Castleman disease 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Angiolymphoid hyperplasia Castleman disease 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Congenital microtia Headache 0.091 1 6.46e-4 1.09e-3 ✓ sig.
Angiofollicular ganglionic hyperplasia Headache 0.091 1 6.46e-4 1.09e-3 ✓ sig.
Angiolymphoid hyperplasia Headache 0.091 1 6.46e-4 1.09e-3 ✓ sig.
Castleman disease Headache 0.091 1 6.46e-4 1.09e-3 ✓ sig.